Position in NVS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$11,143,105
+$644,903 QoQ
Shares Held
71,102
+3.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#164
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. NVS ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
This page
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,143,105 | 71,102 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $10,498,202 | 68,728 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $735,812 | 5,337 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $684,416 | 5,337 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $648,855 | 5,362 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $607,231 | 5,447 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $619,086 | 6,362 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $731,757 | 6,362 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $677,298 | 6,362 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $622,167 | 6,432 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $650,448 | 6,442 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $554,525 | 5,444 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $546,528 | 5,416 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $493,764 | 5,367 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $491,430 | 5,417 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $402,624 | 5,297 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $454,940 | 5,382 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $418,655 | 4,771 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $437,175 | 4,998 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $406,528 | 4,971 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $435,306 | 4,771 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $414,065 | 4,844 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $428,995 | 4,543 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $388,189 | 4,464 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $389,885 | 4,464 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $366,407 | 4,444 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||